Pseudoachalasia of the Cardia Secondary to Nongastrointestinal Neoplasia

• Published in: Dysphagia Vol. 23; no. 2; pp. 122 - 126
• Main Authors: Ulla, Jose Luis, Fernandez-Salgado, Estela, Alvarez, Victoria, Ibañez, Alberto, Soto, Santiago, Carpio, Daniel, Vazquez-Sanluis, Javier, Ledo, Luis, Vazquez-Astray, Enrique
• Format: Journal Article
• Language: English
• Published: New York Springer-Verlag 01.06.2008; Springer Nature B.V
• Subjects: Adenocarcinoma - complications; Aged; Aged, 80 and over; Botulinum Toxins, Type A - therapeutic use; Colonic Neoplasms - complications; Deglutition Disorders - diagnosis; Deglutition Disorders - etiology; Diagnosis, Differential; Esophageal Achalasia - drug therapy; Esophageal Achalasia - etiology; Esophageal Achalasia - physiopathology; Gastroenterology; Hepatology; Humans; Imaging; Male; Medicine; Medicine & Public Health; Neuromuscular Agents - therapeutic use; Original Article; Otorhinolaryngology; Paraneoplastic Syndromes; Radiology; Urologic Neoplasms - complications; Deglutition; Paraneoplasic syndrome; Urologic neoplasm; Deglutition disorders; Pseudoachalasia
• ISSN: 0179-051X; 1432-0460
• DOI: 10.1007/s00455-007-9104-5

A minor proportion of patients with achalasia eventually have a neoplasm and, as a consequence, pseudoachalasia is diagnosed. A neoplasm may either involve gastrointestinal junction or present a paraneoplastic effect. Over the global diagnoses of achalasia issued in 5 years of experience in our motility unit, we have found 13% (3/23 cases) of pseudoachalasia (2–4% in previous series, probably due to the fact that the population assisted was mainly composed of elderly patients). The origin of the neoplasm was bladder, prostate and metastases from epidermoid carcinoma of vocal chord. Treatment of primary neoplasm, besides classical approach (with dilatation of botulinum injection) may help in the resolution of this clinical disorder.